Rituximab during pregnancy in neuromyelitis optica: A case report
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 16, 2018
- Accepted in final form December 10, 2018
- First Published February 1, 2019.
Author Disclosures
- Jahir Miranda-Acuña, MD,
- Erica Rivas-Rodríguez, MD,
- Michael Levy, MD, PhD,
- Mustafa Ansari, MS,
- Roslynn Stone, PharmD, PhD,
- Vivek Patel, MD and
- Lilyana Amezcua, MD, MS
- Jahir Miranda-Acuña, MD,
NONE
NONE
Travel grant by ACTRIMS 2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Erica Rivas-Rodríguez, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michael Levy, MD, PhD,
Asterias, Chugai, Alexion
NONE
NONE
Editorial Board member of Multiple Sclerosis and Related Disorders
1. Aquaporin-4 sequence that elicits pathogenic T cell response in animal model of neuromyelitis optica. 2. Description: patent covers use of peptide for diagnostic and therapeutic developments.
NONE
NONE
Guidepoint Global; Gerson Lehrman Group; Cowen Group
NONE
NONE
NONE
Viropharma/Shire, Acorda, ApoPharma and Sanofi, Genzyme, Alnylam, Alexion, Terumo BCT
National Institute of Neurological Diseases and Stroke
NONE
Guthy-Jackson Charitable Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Mustafa Ansari, MS,
NONE
NONE
Speaking honorarium in the amount of $1500 for MS Views and News
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
USC Keck Medical Center
National MS Society
NONE
NONE
NONE
NONE
NONE
NONE
- Roslynn Stone, PharmD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Vivek Patel, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lilyana Amezcua, MD, MS
1) Celgene 3) Genzyme
NONE
NONE
NONE
1) Short-film documentary about Multiple Sclerosis in the Hispanic community
NONE
NONE
1) Celgene 2) Genzyme
NONE
NONE
NONE
1)Medday 2) Biogen
1) NIH NINDS
NONE
1) Guthy?Jackson Charitable Foundation 2) National Multiple Sclerosis Society 3) California Community Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- From the USC MS Comprehensive Care Center (J.M.-A., E.R.-R., M.A., L.A.), Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA; Department of Neurology (M.L.), Johns Hopkins University, Baltimore, MD; Department of Neurology and Pharmacology (R.S.), University of Southern California; and Department of Ophthalmology (V.P.), Roski Eye Institute, University of Southern California, Los Angeles, CA.
- Correspondence
Dr. Amezcua lamezcua{at}usc.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinningJohn N. Ratchford, Shiv Saidha, Elias S. Sotirchos et al.Neurology, December 24, 2012 -
Article
Disease-modifying therapies modulate retinal atrophy in multiple sclerosisA retrospective studyJulia Button, Omar Al-Louzi, Andrew Lang et al.Neurology, January 11, 2017 -
Article
Optical coherence tomography is highly sensitive in detecting prior optic neuritisSarah Chaoying Xu, Randy H. Kardon, Jacqueline A. Leavitt et al.Neurology, January 23, 2019 -
Article
Interferon-β Is Less Effective Than Other Drugs in Controlling the Rate of Retinal Ganglion Cell Loss in MSYuyi You, Michael H. Barnett, Con Yiannikas et al.Neurology: Neuroimmunology & Neuroinflammation, February 17, 2021